I am taking the trading approach and techniques that helped me build a generously winning track record and sharing it with a select group and you are in!
In the years I was a prop trader for a top bank, I was forced to find great trades consistently, even when it looked like there weren’t any to be found. Since then, I have been helping teach traders what worked AND what didn’t. The thing is, I have found teaching helps me continue to discover new ways to exploit market moves and grab the best possible trades.
That is why I launched Trading Advantage. You get the benefit of seeing what I am watching and why it caught my eye and I get to keep finding new ways to spot winning trades.
I wanted to make sure it gets to people who are engaged in trading and want to learn but if it isn’t for you, I understand, and you can unsubscribe at any time. But if you want to have me give you a quick glimpse into what’s on my trading radar make sure you keep opening these messages and don’t let them go to spam!
If you’re looking for a hot investment theme, dig into artificial intelligence (AI).
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030.
Fueling the story, OpenAI released ChatGPT, a free chatbot that’s become wildly popular. For one, according to Medium.com, “One of the primary reasons ChatGPT is disruptive is that it represents a significant advancement in the ability of AI systems to understand and generate human-like text.” Two, “it has the potential to revolutionize the way we interact with AI.”
Even the White House has taken notice.
In fact, the White House and the European Union agreed to work together to develop new AI tools. According to National Security Advisor Jake Sullivan:
“This collaborative effort will drive responsible advancements in AI to address major global challenges with a joint development model and integrated research to deliver benefits to our societies through five key areas of focus: Extreme Weather and Climate Forecasting, Emergency Response Management, Health and Medicine Improvements, Electric Grid Optimization, and Agriculture Optimization.”
While we can always invest in AI stocks, such as Microsoft, Nvidia, C3.AI, Splunk, and even Palantir, we can own more for less with an ETF.
Not only do ETFs allow you to diversify with dozens of top AI names, they allow you to do so at a lower cost. For example, the Global X Robotics & Artificial Intelligence ETF (BOTZ) offers exposure to 42 stocks. It traded at $25.70. If I were to buy 100 shares of the ETF, it would cost me $2,570. However, if I were to buy just one of the top BOTZ holdings – Nvidia, for example, it would cost me about $29,000 for just that one stock.
Price Range – Stocks above $20 are generally not going to give us the best return on our investment, since we have to invest much more money and premium prices will not necessarily be any higher. For example, buying 100 shares of a stock that costs $10 a share then writing a covered call paying a premium of $1 per share, would give you a 10% return on investment (100 shares cost $1,000: 100 shares pays $100 premium).
(Profit / Cost) x 100 = % Return
($100 / $1,000) x 100 = 10%
But an expensive stock will not necessarily pay any higher premium. Buying 100 shares of a high priced stock, say $50 a share, which also pays a premium of $1 per share, would only yield 2% return.
Elite Wall Street trader, Joe Duffy, is allowing a limited group of future-elite investors into his masterful daily trades at thousands of dollars less than what others charge.
When you join today for $1, the first month you'll receive:
Joe Duffy’s daily video newsletter with updates on what's happening in the markets that very day. Rather than watch talking heads for hours on cable, I'll get you up to speed in minutes.
You get weekend updates where I delve more into 'bigger picture' looks at the marketplace. Videos are illustrative, instructive, concise, and un-hedged. No double talk here.
The first profit opportunity we will review is ROIV, Roivant Sciences, Ltd. ROIV focuses on therapies through wholly- or majority-owned subsidiary companies including, Axovant, Myovant, Dermavant, Enzyvant, and Urovant.
The monthly chart shows that ROIV has been above the moving average line since October. If the stock price is above the moving average line, the trend is up.
The daily chart shows that ROIV went almost straight up from the September low until the January high. The overall trend since then has been sideways. Sideways trading in a bull trend is usually followed by a further advance.
We recommend buying ROIV stock at the current price level.
PLEASE READ: Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC’s website: All About Auto-Trading, TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.
1) The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the “Services”) is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing (“TradeWins”) a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis.
2) TradeWins’ Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.
3) Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services (“Subscriber”) should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.
4) You should trade or invest only “risk capital” – money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.
5) All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.
6) Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.
7) No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.
8) The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber’s own election and for the Subscriber’s own risk.